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What does this review add to the existing literature and how will it influence future 20 
clinical practice: This article describes the first comprehensive systematic review of patient 21 
education interventions for physical activity (PA) improvement for individuals with 22 
intermittent claudication. The current evidence is inconclusive regarding the effect of 23 
patients’ education on PA of individuals with IC. Further research is warranted to establish 24 
the effects and optimal design of education interventions. 25 
 26 
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Objectives: To review the components and effects of patient education interventions to 32 
improve PA in patients with PAD and IC, and patients’ experiences of these interventions. 33 
Data Sources: CINAHL, Cochrane Library, Ovid, ProQuest, AMED, MEDLINE, 34 
PsycINFO, Web of Science Core Collection, and PEDRO, and Trial registers and directory of 35 
Open-Access repository websites and Web of science conference proceedings were searched. 36 
Hand searching of reference lists of identified studies was also performed to identify studies 37 
that reported the effect of patient education interventions on daily PA and/or walking 38 
capacity in individuals with PAD and IC, or studies investigating patients’ experiences of 39 
such interventions.  40 
Review Methods: A systematic search was conducted in June 2016 (updated in March 41 
2017). Primary outcomes were daily step count and self-reported PA; the secondary outcome 42 
was absolute claudication distance. There was substantial heterogeneity in terms of 43 
modalities of patient education in the included studies; hence a narrative synthesis 44 
was implemented. 45 
Results: Six studies (1087 participants) were included in the review. Findings from a small 46 
number of high-quality trials demonstrated potential for PA improvement with structured 47 
education interventions. Nevertheless, evidence is currently inconclusive regarding the effect 48 
on daily PA and walking capacity of patients with IC. Patients reported that they valued the 49 
interventions studied, finding them acceptable and important in improving their PA, 50 
motivating and empowering them to self-manage their condition. 51 
Conclusions: The evidence from the review is limited and inconclusive regarding the 52 
effectiveness of structured education for increasing PA in patients with PAD and IC. More 53 
rigorous trials are needed before recommendations can be made. Future interventions should 54 
4 
 
consider the key criteria for a structured patient education programme, and also report 55 
patients’ experiences and perceptions. 56 
Abstract word count: 274 57 
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Peripheral arterial disease (PAD) is a growing public health burden. PAD leads to arterial 63 
stenosis and consequently inadequate blood flow to the peripheries.
1,2
 This commonly 64 
presents as  pain in the lower limb(s) precipitated by exercise and relieved by rest,
3 
defined as 65 
intermittent claudication (IC). Patients with IC experience functional decline and limitation in 66 
physical activity (PA),
4
 further raising the risk of a cardiovascular event in a vascular system 67 




patients with PAD 68 
present with an increased risk of cardiovascular and cerebrovascular events similar to those 69 
with coronary heart disease.
5
 70 
Lower daily PA levels have been recognised as a strong predictor of increased morbidity and 71 
mortality in this population.
6 
Supervised exercise programmes (SEPs) are recommended as a 72 
primary therapy for this population,
7 
and have been shown to improve treadmill walking 73 
distances of patients with IC.
8,9 
However, most studies reporting such improvements did not 74 
investigate daily PA, and those that have, did not find improvements in daily PA.
9 
Reduced 75 
self-efficacy, attributed to poor understanding of the disease and uncertainty regarding the 76 
importance of walking has been identified as a major barrier to exercise uptake in this 77 
population.
10,11 
These findings suggest that a patient-centred self-management approach to 78 
improving PA, including structured patient education, may be beneficial in this population.  79 
Although current literature supports educating patients with IC about their disease pathology 80 
and the importance of walking,
10,11 neither evidence of effectiveness nor patients’ perceptions 81 
of interventions have been established. The aim of this review is to examine the effect of 82 
patient education for improving PA in individuals with PAD and IC and the experiences and 83 





The protocol for this review was registered with the International Prospective Register of 87 
Systematic Reviews (CRD42015027314), and has been published elsewhere.
12
 88 
Eligibility Criteria 89 
Studies reporting the effect of patient education interventions on daily PA and/or walking 90 
capacity in individuals with PAD and IC, or studies investigating patients’ experiences of 91 
such interventions were included in this review. Diagnosis of PAD could be objective (eg, an 92 
ankle–brachial index (ABI) <0.9), by questionnaire or clinical diagnosis. Original English 93 
language research manuscripts in peer review journals and conference proceedings were 94 
included. Studies were included only if they reported on structured patient education 95 
interventions and/or components particularly related to PAD and IC. For the purposes of this 96 
review, the key criteria used to define structured education in diabetes were adopted.
13
 To be 97 
included, a patient education intervention should:  i) aim to empower and inform patients, and 98 
to support self-management of their PAD/IC by building sufficient knowledge and skills to 99 
do so; ii) include topics about the nature of PAD/IC, and day-to-day living and management 100 
of PAD/IC including importance of physical activity and walking; iii) have embedded quality 101 
assurance processes including having a structured curriculum, having trained educators, being 102 
quality assured, and being audited.  103 
Outcomes 104 
Daily PA (daily step count and self-reported change in daily PA) was the primary outcomes. 105 
Secondary outcomes included treadmill measured walking capacity (absolute claudication 106 
distance (ACD)), pain intensity, quality of life, and qualitative data regarding patients’ 107 
experiences with interventions.  108 
Information sources, search strategy, study records and data management 109 
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A systematic search was conducted in June 2016 (Updated in March 2017). Nine databases 110 
(CINAHL, Cochrane Library, Ovid, ProQuest, AMED, MEDLINE, PsycINFO, Web of 111 
Science Core Collection, and PEDRO), trial registers and directory of Open-Access 112 
repository websites were searched by the first author (UOA) using key words: patient 113 
education, lifestyle education, behaviour change intervention, peripheral arterial disease, 114 
intermittent claudication, physical activity and homebased exercise combined with specific 115 
search terms and strategies for each database.
12
 Reference lists of identified studies were also 116 
searched. Titles, abstracts and full text of selected studies were independently screened by 117 
two authors from a pool of three (UOA, CS, PD) using previously defined eligibility 118 
criteria.
12
 Differences of opinion regarding inclusion or exclusion were resolved by 119 
discussion between authors and reflection in consultation with the second author (PD).  120 
Data collection Processes  121 
The Cochrane Consumers and Communication Review Group Data Extraction Template,
14
 122 
and the Supplementary Guidance for Inclusion of Qualitative Research
15 
were adapted to 123 
extract data from the included studies. The Cochrane Collaboration risk of bias tool was used 124 
to determine and summarise risk of the included studies.
16
 Assessment was made in each of 125 
the included studies and graded as ‘high risk’ or ‘low risk’ following a well described 126 
procedure.
17
 Studies were subsequently rated as low-quality trials (i.e. having high risk of 127 
bias) or high-quality’ trials (i.e. having low to moderate risk of bias) if there were ≥3 or <3 128 
identifiable sources of bias respectively (Table 2). Two reviewers (UOA, CS) performed the 129 
data extraction, and made judgements regarding the risk of bias independent of each other 130 
independently. Again any disagreement was resolved by discussion between the reviewers 131 




Study inclusion  134 
The search initially identified a total of 5707 studies (Figure 1), of which six studies, 135 
contributing data on 1087 participants were included in the final analysis. Meta-analysis was 136 
not possible due to wide variations in interventions and substantial methodological and 137 
clinical heterogeneity in the included studies. The results of this review are reported using 138 
narrative synthesis.  139 
Characteristics of included studies 140 




 and one was a pretest-postest design.
32  





. The basis for IC diagnosis in most (n=4) studies was post exercise 143 
ABI≤0.9.18,20,22,30 Clinical characteristics between the intervention and control groups were 144 
similar at baseline for all included studies, except for one study
22
 where the control group had 145 
a higher resting heart rate and weight (Table 1). Overall, four of the six trials were rated as 146 
high-quality
18-20,22
 (Table 2). No study was assessed to have a risk of bias related to selective 147 
reporting. Sources of bias in included studies included lack of blinding of outcome 148 
assessment (n=5),
18--21,
 lack of allocation concealment (n=3),
18,19,23  
lack of participants and/or 149 
personnel blinding (n=3),
21-23 
and  not being powered to detect an effect size (n=4).
18,19,21,22
 150 
Components of interventions in included studies 151 
The included studies had wide variation in the intervention components used, but all included 152 
an education session, exercise prescription, and some behavioural change techniques (BCTs) 153 
(Table 1). Information provision, goal setting, action planning and feedback were reported in 154 
all included studies. Other reported BCTs included motivational interviewing (n=3), barrier 155 
identification/problem solving (n=5), feedback on performance (n=2), and prompting self-156 
monitoring of behavioural outcome (n=4). Intervention duration ranged from 6 weeks
19 
to 4 157 
months.
18
 Most studies (n=4) instructed patients to walk through moderate-to-severe leg pain. 158 
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Control participants either received usual care,
18,19,22 





 One study did not include a control group.
23
 160 
Outcomes reported in included studies 161 
Five studies
18-20,22,30 
reported walking capacity outcomes, and three
18,19,21
 reported outcomes 162 
of daily PA. Walking capacity outcomes included treadmill walking distances and time, six 163 
minutes walking distance, WELCH score, walking impairment questionnaire speed, distance 164 






18,19,23 reported outcomes on patients’ 166 
experiences to interventions. Other outcomes reported included pain intensity,
23
 self-efficacy 167 
and self-esteem,
19 




Effect of interventions in included studies 170 
Except where specified otherwise, effects of intervention are reported as comparison of the 171 
intervention versus the control.  172 
Daily physical activity outcomes 173 
Self-report daily physical activity outcome. Two studies provided data on self-report of daily 174 
PA.
20,21
 A high-quality trial,
20
 showed no difference between percentage of participants who 175 
engaged in walking for recreation ≥3 times per week (36.8 vs 31.4%; p=0.14), engaged in 176 
more than usual activity (10.2 vs 9.0%; p=0.73), or belonged to an exercise group (14.0 vs 177 
10.1%) at 2-months. However, at 12 months follow up, a greater percentage were walking ≥ 178 
3x/week (33.8 vs 25.0%; p=0.01), engaged in more activity than usual (11.1 vs 5.9%; 179 
p=0.03), or belonged to an exercise group (16.5 vs 1.8%; p<0.001). The other trial was of 180 
low-quality
31
 and reported no change in time spent in various levels of activity. 181 
Objectively measured daily physical activity outcome. Data on daily step counts were 182 
available from two high-quality trials.
18,19
 At 4 months, Cunningham et al
18 
reported a greater 183 
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increase in daily step count (1575; 95% CI 732 to 2419; p<0.001). In contrast, Tew et al.,
19
 184 
did not find improvement in daily step count of their patients after a six-week intervention 185 
(440; 95% CI -827 to1708; p>0.05).  186 
Walking capacity  187 
Five studies
18-20,22,23
 reported outcomes on walking capacity. One pretest-posttest study
23
 188 
reported significant improvement in ACD: increases of 63% at 3 months, and 84% at 6 189 
months compared to baseline. Similarly, one high-quality pilot RCT
19
 reported a significant 190 
increase in ACD at 6 weeks (173; 95% Cl 23-332)  Another high-quality trial
20 
found no 191 
change in the number of people whose ACD improved, remained same or deteriorated at 2-192 
month follow up. However, a significantly greater number of patients were found to have 193 
improved their maximum walking distance (p=0.003) at 12 months. 194 
Quality of life and other outcomes 195 
Five trials,
18-20,22,23
 reported outcomes related to quality of life (QoL). Generally, outcomes of 196 
both general and disease specific QoL were mixed. One high quality trial showed 197 
improvement in SF-36 (0.40 vs -0.30; p=0.002) but no change in ICQ score (p>0.05) at 4 198 
months.
18
 In contrast, another high quality pilot trial
19 
reported improvement in ICQ (-10.6; 199 
95% CI -18.9 to -2.3) but not general QoL (EQ-5D utility score 0.05; 95% CI -0.09 to 0.19). 200 
Two high-quality trials reported no change in health related QoL at two months (0.83 vs 085; 201 
p=0.33), and at 12-months follow-up (0.83 vs 0.84; p=0.13)
20
 or in general QoL at 14 202 
weeks.
22
 A low quality trial however, reported post-intervention improvement in the physical 203 
component of SF-36 score at both 3 months (40.8 vs 36.0; p<0.01) and at 12-month follow-204 
up (42.3 vs 36.0; p<0.01) compared to baseline.
33
 For this trial, there was also an 205 
improvement in the mental composite score at 3 months (45.2 vs 41.6; p<0.05) but not at 12 206 




A high-quality trial reported an improved walking performance self-efficacy (mean adjusted 209 
difference 29.5; 95% CI 12.6-46.4) and perceived control over illness (mean adjusted 210 
difference 2.4 95% CI 0.0-4.7).
19
 A low-quality trial
23
 reported a decrease in pain intensity at 211 
3 months compared to baseline (5.89 vs 4.73, p<0.05), which remained stable during the 212 
following 9 months (5.89 vs 4.53; p<0.05). Also, the time taken for claudication pain to 213 
disappear improved at 6 month from baseline (3.95 vs 2.01; p<0.05), and remained stable for 214 
the following 6 months (3.95 vs 2.83; p<0.05). 215 
Patients experiences with interventions 216 
Three studies
18,19,23
 reported qualitative findings related to the experiences of patients with 217 
education interventions. Sixteen qualitative findings were extracted from the papers and 218 
grouped into eight categories. These categories were then merged to create three synthesised 219 
themes: Acquiring knowledge; Receiving pragmatic and tailored care; and Gaining 220 
confidence and self-monitoring (Tables 4 and 5). Although verbatim quotes were not 221 
available from the included papers, each synthesised theme is described below with some 222 
examples which reflect the patients’ experiences, as reported in the included papers.  223 
Acquiring knowledge: Acquiring knowledge entails patients being provided information 224 
about their pathology and the systemic nature of IC, being informed of the importance of 225 
secondary prevention and risk factor modification including the importance of PA. Tew et 226 
al.
19
 reported that patients valued a 6-week programme of pragmatic group-based structured 227 
patient education because it provided them with greater understanding of their condition, and 228 
empowered them to walk more.  229 
Receiving pragmatic and tailored care: Patients valued the idea of a group-based 230 
intervention which also gave opportunity for individual attention. Prevost et al.
23
 reported that 231 
97% of the participants were satisfied with the quality, duration, topics discussed as well as 232 
12 
 
the group nature of the session. Similarly, 95% reported that they were satisfied with the 233 
scope, quality, and benefit of individual discussion.  234 
Gaining confidence and self-monitoring: Gaining confidence encompassed developing a 235 
positive self-attitude, overcoming uncertainties, and feeling empowered. Gaining confidence 236 
to self-monitor their daily step counts with a pedometer: patients were presented with the 237 
opportunity to self-monitor their progress and they considered this an important component 238 
for meeting their physical activity goal.  Prevost et al.
23
 reported that their participants were 239 
very satisfied with the improvement in their attitude toward walking with claudication and 240 
their physical self-confidence and valued the use of pedometer as a tool for motivation, self-241 
monitoring, and goal setting. 242 
Discussion 243 
Six trials evaluating a range of patient education interventions for improving PA in patients 244 
with PAD and IC were reviewed. The included studies were mostly of high methodological 245 
quality. The major sources of risks of bias were lack of blinding of outcome assessment, 246 
performance bias and lack of allocation concealment. Combined evidence from four studies 247 
indicated that structured patient education intervention increased maximal walking 248 
capacity
19,23
 and improved daily PA,
18, 20
 however, similar number of studies demonstrated no 249 
change in maximal walking capacity,
20,22
 and free-living PA.
19,20 
 Generally, while daily step 250 
count tended to improve only after longer period of follow up (4 months upwards), there was 251 
no such trend for the outcomes related to maximal walking distance. Evidence from five 252 
trials
18-20,22,23
  showed marked variability regarding quality of life measures. Useful 253 
interventions from the patients’ perspective included those that provided them with 254 
information about their condition, were designed to enhance group interaction while 255 




Related reviews have been conducted on behaviour change techniques
24
 and home-based 258 
exercise programmes
25
 for PA improvement in this population. Galea et al.
24 
reported limited 259 
evidence from one high-quality RCT to support BCTs for improving maximal and pain free 260 
walking capacities, and for increasing daily PA among people with IC. Similarly, Al-Jundi et 261 
al.
25
 reported that there is “low-level” evidence that home-based exercise programmes can 262 
improve walking capacity and quality of life in patients with IC.  However, the reviews were 263 
limited to RCTs of BCT,
24
 or primarily reported outcomes related to walking capacity rather 264 
than daily PA.
24,25
 No review has considered the qualitative experiences of patients with these 265 
interventions. Further, although these reviews include studies with patient education 266 




Possible explanations for the contrasting findings in the current review may be related to the 269 
heterogeneity of study design.  One
23
 of the studies employed a prepost-posttest design 270 
therefore lacked a control group, and had high risk of bias including selection, detection, and 271 
performance bias. In another trial,
21
 it was difficult to completely rule out possible 272 
contamination of the control group as both groups received some form of patient education.  273 
One study
22
 included patients who underwent vascular intervention in the weeks prior to the 274 
intervention, and one patient who did not report claudication pain during treadmill testing. 275 
Furthermore, the large variations in patient education modalities and components warranted 276 
different contact time, duration of intervention, time point of outcome assessment, and 277 
intervention components, possibly resulting in wider outcome variability.  278 
The high-quality pilot trial by Tew al al.,
19
 which applied a 6-week structured education 279 
intervention demonstrated potential for increasing PA early in the programme, was 280 
particularly rigorous with blinded outcome assessment demonstrating improvement in 281 
walking capacity at 6 weeks. Although no change in daily step count was observed, it is 282 
14 
 
possible that the effect of behaviour change interventions takes longer to be noticeable. There 283 
could be other factors that mediate a slow response to adapting PA change in patients with 284 
PAD and IC even when the disease pathology is understood. One possible barrier is the 285 
claudication pain which these patients experience even when they are motivated to walk.  286 
Current NICE guidelines recommend “encouraging claudicants to exercise to the point of 287 
maximal pain.”7 Perhaps for patients with IC to gain the benefit of secondary prevention, 288 
concomitant pain management may be desirable to delay the onset and reduce the intensity of 289 
pain. By delaying peak maximal pain and empowering patients through education the 290 
potential therapeutic value of walking not only could be realised early in the programme, but 291 
may be sustained. 292 
Structured Exercise Programmes are the recommended exercise therapy for IC, however, 293 
based on the small number of included trials, most exercise programmes either do not 294 
incorporate patient education, or do not typically comply with criteria definitions of a 295 
structured education programme.
12
 While ‘usual care’ patient education is included in the 296 
NICE SEPs recommendations for secondary preventions in IC, the development and 297 
implementation of the education components in SEPs interventions are not sufficiently 298 
reported to allow a judgement of their fidelity. Therefore, it is often not known how 299 
education was delivered, whether educators were sufficiently trained, whether education 300 
interventions were delivered as intended, and/or whether sufficient topics are included to 301 
enhance patient self-management skills. These elements are important as not only do they 302 
underpin the potential effectiveness of education programmes, they may be crucial in 303 
translating gains in a hospital based SEPs intervention to sustained improvement in daily 304 
physical activity at the end of the 3 months SEP duration, which is crucial in managing 305 
chronic diseases such as PAD/IC. 306 
15 
 
Only three of the included papers reported patient experience with interventions. In these 307 
trials, patients reported that they valued interventions that improved their understanding of 308 
the diseases pathology of PAD and IC, and provided them with information of the importance 309 
of walking and how walking helped. For these patients, gaining confidence, self-monitoring 310 
ability and skills were key to their accepting and perhaps adhering to interventions. Other 311 
important components according to the patients were the benefits from socialising in a group 312 
session without losing the opportunity for individualise care. The interventions that included 313 
these components demonstrated improvement in both maximal walking capacity,
19,23




Several limitations are recognised regarding the conclusions in this review. First, the planned 316 
meta-analysis could not be implemented due to heterogeneity in the included studies. 317 
Secondly, although four of the six included papers were of high quality, three were pilot trials 318 
assessing outcomes after a relatively short time point. For instance, Tew et al.
19 
only had 13 319 
or 9 participants in each group and assessed outcomes after just a 6-week intervention. This 320 
means that an inadequate sample and early assessment of outcome could limit the statistical 321 
power. Thirdly, the time point of outcome assessments were so varied that it was difficult to 322 
establish a reference time point to assess outcome performance even in a narrative synthesis. 323 
Fourthly, lack of a control group or use of an active control group meant that the specific 324 
efficacy of the intervention versus the usual care or nothing could not be clearly ascertained. 325 
In addition, the review design itself has inherent limitations; non-English language literature 326 
and unpublished literature was not searched or reviewed. 327 
Limited evidence from four trials is inconclusive regarding the effect of structured patient 328 
education to improve daily PA, and walking capacityof patients with IC. Interventions that 329 
provided patients with information about their disease pathology and walking, provided 330 
motivation and empowered patients were valued, acceptable and seen by patients as 331 
16 
 
important in improving their PA. Structured education programmes may prove to be an 332 
essential part of exercise programmes for patients with IC but, rigorous trials are required 333 
before this can be recommended. Future interventions should consider the key criteria for a 334 
structured patient education programme. In addition, reporting on patients constructs of their 335 
experiences and perceptions to the interventions should always be factored in and reported so 336 
that holistic evaluation of effective components from the patients’ perspective can be 337 
undertaken. 338 
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Figure 1: Patient Education review PRISMA Flow Diagram 
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Removed as duplicates 
(n=4222) 
Records screened by 
titles and/or abstract  
(n= 1887) 
Records excluded after title 
and abstract screening  
(n=1871) 
Full-text articles 
assessed for eligibility  
(n=16) 
Excluded after reading full-text 
articles, with reasons (n=10) 
Editorial (n=1) 
Participants without IC or PAD 
(n=4) 
Same cohort (n=2) 
Separate effect of PE not clear 
(n=1) 
All group received PE (n=1) 
No education intervention 
(n=1) 
 
Studies included in 
descriptive/Narrative 
synthesis (n=6) 

























Total n = 58 
, IC in at least one leg  
Post-exercise ABI<0.7 
 
Intervention: Usual care + Information on PAD and 
walking, motivational interviewing, PA goal setting, 
action planning, self-monitoring and feedback, barrier 
identification with problem solving. Delivered at patients’ 
homes by via a trainee health psychologist 2 x 1-hr 
sessions 
 
Control: Usual care (walking advice + consultation with 
vascular surgeon)  
Daily steps (pedometer) 
 




quality of life) 
 
Medical Outcome Study 
Short-Form (generic 
health-related quality of 
life)  
 
Outcomes assessed at 
baseline and 4 months  
 
Brief psychological intervention 
significantly improved walking 
behaviour in patients with IC in 










High quality  
 
4.35% 
Total n = 23  
 
Stable Rutherford IC 
Classification 1-3 for 
≥3months. 
 
Intervention: Usual care plus one off 3-hr session of 
group patient centred structured education including 
patient story, PAD/IC and walking information provision, 
PA feedback, barrier identification with problem solving, 
goal setting, action planning, and self-monitoring. 
Delivered at in clinical research facility followed by 
twice-weekly phone calls for 6 weeks. 
 




ICD, 6-minute walk test 
 
WELCH questionnaire  
 
ICQ (disease-specific 
quality of life) 
 
EQ-5D (generic health-





Education programme is feasible, 
acceptable, and potentially useful 
for improving walking capacity 







Outcomes assessed at 














Total n = 882  
 
ABI ≤0.9  
Clinical diagnosis of PAD  
Definite IC or atypical IC 
on Edinburgh Claudication 
Questionnaire  
Intervention: Educational package + mobility program 
(supervised or home-based) + smoking cessation where 
applicable  
 
Control: No intervention 
ICD  
 
PA pattern (Patient 
report)  
 
Medical Outcome Study 
Short-Form (generic 
health-related quality of 
life)  
 
Outcomes assessed at  
baseline, 2 months, and 
12 months  
 
Intervention for early PAD based 
on increased PA &Smoking 
cessation results in a greater max 











Total n = 51, Diagnosis of 
PAD  
ABI >0.5 & ≤0.955. 
 
Intervention: Communication intervention beginning with 
completion of guide and followed by 15-20 minutes of 
motivational interviewing, provision of information 
related to PAD/IC and walking, barrier identification and 
problem solving strategies, patient tailored walking 
prescription. Delivered by medical student.  
 
Control: Video Intervention 
PA pattern and time 
(patients report) 
 




Outcomes assessed at 
baseline, and 12 weeks. 
 
 
-Patients watching video on the 
use of PA in PAD improved 










Low quality  
Total n = 48 
 
Level II Leriche and 
Fontaine IC 
Atypical symptom 
ABI<0.9;   
 
Intervention: Educational classes, implementation of 
secondary prevention, and a personalised program of 
reconditioning exercises.  
 
Control: No intervention 
ICD and ACD 
 
Medical Outcome Study 
Short-Form (generic 
health-related quality of 
life) 
 
Educational therapeutic program 
results in a significant 
improvement in functional and 
QoL parameters during the first 
3months in patients with IC and 






Pain intensity   
 
Patients experiences via 
exit questionnaire 
(12months only)  
 
Outcomes assessed at 










High quality  
 
20% 
Total n = 25 
 
Patients without walking 
limiting comorbidities 
except IC  
Severe cardiac ischemia 
≤3months previous 
myocardia infarction  
TIA or stroke  
< 1month treatment with 
cilostazol or penthoxifylline  
Endovascular therapy 4-
6wks prior baseline Or  
stable IC without 
revascularisation in the last 
4-6weeks (ABI ≤0.9)   
Intervention: Initial in-hospital walking exercise (2 
weeks, 3 days/week) followed by community-based 
walking exercise (12 weeks) with training, monitoring 
and coaching (TMC) components.  
 
Control: Usual care (standard advice to walk)  




Medical Outcome Study 
Short-Form (generic 
health-related quality of 
life) 
 
Outcomes assessed at 
baseline and 14 weeks 
Community-based walking 
exercise with TMC improves ICD 
and walking performances other 
than ACD.  
 
 
Key: IC = intermittent claudication; ABI = Ankle brachial index; RCT; Randomised control trial; ACD = Absolute claudication distance; ICD = Initial claudication distance; 
NS = not significant, PA= Physical activity, WIQ =walking impairment questionnaire; ICQ = Intermittent claudication questionnaire, EQ-5D = EuroQoL EQ-5D-5L, 





Table 2: Risk of bias in individual studies 
Authors 
*
Sources/ Potential sources of bias 
Summary 









































































The Cochrane Collaboration tool for assessing risk of bias was used to determine and summarise possible sources of risk of bias in included 
studies (Cochrane 2011) (
*
Yes indicates the presence or potential presence of a source of bias).
*
Summary risk of bias in included studies was 
presented. 
†
Studies were subsequently rated as low-quality trials (i.e. having high risk of bias) or high-quality’ trials (i.e. having low to moderate 





Table 3: Data extraction of finding from included studies (Except where specified, results are presented as intervention group compared to control group)  
Authors Change in Daily PA behaviour PA Capacity/Ability measures  Pain, Self-efficacy, and Perceived 
control over illness. 
Quality of life 
Mays et al.
22
  At 14 weeks: 
Pain free walking time (p= NS); 
 
Greater increase in caudication onset time 
(5.8±1.5min to 7.4±1.6min vs 4.7±1.4min → 
4.1±1.5min; p=0.045); 
 
Greater improvement in walking impairment 
(42.3±7.7min → 60.6±7.2% vs 49.1±7.7 → 
44.6±7.2%; p=0.001). 
 At 14 weeks: 
 
General QoL (p=NS) 




 Significant % increase in ICD from baseline 
(277% at 3months, 203% @ 6months, 141% 
@ 12months; p<0.001) 
 
Significant % increase in ACD from baseline 
(63% @ 3months; 84% @ 6months; 65% @ 
12month; p <0.01). 
Decrease in pain intensity at 3, 6, 
12months from baseline (5.89→ 
4.73* → 4.34α → 4.53*)  
 
Improved from baseline in Time of 
release of pain at 6 months, and 
12months(3.95
 →2.01α → 2.83α) 
Improvement from baseline in 
physical composite score  of SF-
36 at 3, 6, & 12months (36.0→ 
40.8→ 41.9→ 42.9; p<0.01) 
  
Improvement from baseline in 
the mental composite of SF-36 
at 3 and 6 months (41.6→ 
45.5→ 44.7→ 44.2; p<0.05) 
Cunningha
m et  al.
18
 
At 4 months: Greater increase in daily 
steps (1358 vs -227; p<0.001) 
At 4 months: *Greater pain-free walking 
distance (1.00 vs 0.00; p=0.008) 
 At 4 months: 
Improvement in general QoL 
(0.40 vs -0.30; p=0.002) 
 
Disease specific QoL (p=NS) 
Tew et al., 
2015 
At six weeks : Daily steps (p=NS) At six weeks:  
Improvement in Six-minute walk distance 
(44.9; CI 6.9 to 82.9); 
Greater increase in ACD (173; CI 23 to 322); 
ICD  p=NS 
Greater improvement in self-reported walking 
ability WELCH score (21.8; CI 8.6 to 35.0);   
WIQ Speed (21.0; CI 3.8 to 38.1), WIQ 
distance (30.7; CI 6.4 to 55.0), WIQ stair 
climbing (30.7; CI 6.4 to 55.0). 
At six weeks: 
Improvement in walking 
performance efficacy (29.5; CI 12.6 
to 46.4) 
 
Greater improvement in perceive 
control over illness (2.4; CI 0.0  to 
4.7) 
At six weeks:  
Greater improvement in disease 
specific QoL (-10.6; CI -18.9 to 
-2.3) 
 
General QoL (p=NS) 
Fowler et At 2nd months: % of patients walking for At 2nd  month: Self-report  maximum  At 2nd month: HQoL(NS) 
26 
 
al., 2002 recreation ≥3/wk (p=NS); % of patients 
engaging in vigorous PA (p=NS); % of 
patient belonging to exercise group 
(p=NS) 
 
At 12th month: Greater % of patient 
walking for recreation ≥3/wk (33.8 vs25; 
p=0.01);  % of patients engaging in 
vigorous PA (p=NS); Greater % of 
belonging to exercise group (16.5 vs 1.8, 
p<0.001) 
walking distance before the onset of pain 
(p=NS) 
 
At 12th month: Improvement in self-report  
maximum walking distance before the onset 
of pain (p=0.04) 
 
 





Collins et al 
2009 
At 12weeks: Activity patterns in various 
levels of physical activity (p=NS)  
 
 
   
Keys: PWD = Peak walking distance; WIQ = Walking impairment questionnaire; QoL = Quality of life; COT = Claudication onset time; Int = Intervention; Cont = Control; 
grp = Group; NS = No significance; ∆ = Change; HQoL = Health related quality of life; MWD = Maximum walking distance; ACD = Absolute claudication distance; PA = 
Physical activity; ICD = Initial claudication distance; FCD = Functional claudication distance. 










Table 4: Categories: Label and description of patients experiences with intervention 
Category label Category description  
Receiving information 
about disease 
Participants valued participation in the intervention because it provided them with greater understanding of their 
condition (T); Patient valued intervention because it provided them with extra information about their illness(C). 
97% were very satisfied with the topic discussed (P) 
Receiving information 
about walking 
Patients reported that they valued the intervention because it provided them with understanding of the importance 
of walking(C); Patients reported that they valued the intervention because it provided them with understanding of 
how walking will help(C); Patient said intervention were worthwhile and that they valued it because it provided 
them with extra information about walking(C) 
Being motivation and 
empowered 
Patients reported being satisfied with their improvement in attitude towards walking with their claudication and 
their physical self-confidence (P); Patients reported being satisfied with their improvement in their physical self-
confidence (P); Participants valued participation because it enabled them to walk more (T); Patients said they 
valued intervention because it provided them with extra encouragement and motivation(C).   
Benefit of group 
education session 
97% reported that they were very satisfied with the benefit of group education session (P) 
Self-monitoring The use of pedometer was valued as it was seen as useful tool for self-monitoring (T) 
Goal setting Patient reported that intervention were worthwhile because it provided them clarity on what to do(C); 
Pedometer as useful tool Patients valued the pedometer and seen as a valuable tool for motivation, self-monitoring and goal setting (T) 
Receiving personalised 
care 
95.5% reported very satisfied with the scope, quality, and benefit of individual discussion(P); Patients valued the 
intervention because it provided personalised plan(C) 
Key: T: Tew et al.
19
; C: Cunningham et al.
18










Table 5: Developing synthesis findings from the categories 
Synthesised finding Category 
Acquiring knowledge  Receiving information about disease; Receiving information about for walking; Goal setting; Pedometer 
as useful tool 
Pragmatic and tailored care Benefit of group education session; Receiving personalised care 
Gaining confidence and self-
monitoring 
Being motivation and empowered; Pedometer as useful tool; Self-monitoring; Pedometer as useful tool 
 
 
 
